Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Triliogy pays first dividend as FY profit more than triples

Triliogy declares first dividend as annual profit more than triples

By Suze Metherell

May 25 (BusinessDesk) - Trilogy International, the skincare products and scented candle maker, announced its first dividend after annual profit more than tripled on Australian sales growth and the first earnings from its Ecoya candle brand.

Profit rose to $4.5 million in the year ended March 31, from $1.1 million a year earlier, the Auckland-based company said in a statement. Sales increased 23 percent to $36.6 million. The board declared a 3.66 cents per share dividend.

Chairman Geoff Ross said the ongoing dividend policy will be dependent on future growth and acquisition opportunities, but the board intended to keep the payout ratio between 45 percent and 55 percent of after tax earnings.

The result beats Trilogy's March forecasts, when it flagged profit would more than triple while sales would grow at least 18 percent. The company had already beaten expectations for first-half earnings when it reported in November, with strong Australian sales of its Ecoya brand candles accounting for about 42 percent of revenue.

“Both brands performed strongly and profitably during the period, in particular in the New Zealand and Australian markets, with Ecoya moving into profitability for the first time,” said chief executive Stephen Sinclair. “In Australia, the new distribution agreement for Trilogy with McPhersons Consumer Products (MCP) helped to deliver very good results in that market, plus the Ecoya brand grew strongly.”

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

Sales in Australia rose 38 percent to $18 million, making up half of its overall revenue. New Zealand sales increased 15 percent to $10.2 million. UK sales rose 7.8 percent to $2.4 million, US sales dropped 6.2 percent to $776,000, while the rest of the world sales 18 percent to $3.6 million.

Trilogy shares rose 2.2 percent to 95 cents, and have gained 29 percent since the start of the year.

(BusinessDesk)

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.